SCHEMBL14335367

SCHEMBL14335367

O=C(CCCl)NC1CCCc2ccccc21

nearest known ligand 0.80

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.80
TSHR P16473 2/20 0.69
DHODH Q02127 6/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
HPGD P15428 2/20 0.64
MAPT P10636 1/20 0.64
POLB P06746 2/20 0.62
HTT P42858 3/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9171378 0.92 ALDH1A1 (0.76) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL1565743 0.89 ALDH1A1 (0.76) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL2406505 0.89 ALDH1A1 (0.76) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL606143 0.89 ALDH1A1 (1.00) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL53323 0.89 ALDH1A1 (1.00) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL22756633 0.87 ALDH1A1 (0.72) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL4859453 0.86 ALDH1A1 (0.71) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL10806154 0.86 ALDH1A1 (0.71) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL3330158 0.84 MEN1 (0.71) ALDH1A1TSHRDHODHL3MBTL1HPGD
SCHEMBL3151520 0.84 ALDH1A1 (0.67) ALDH1A1TSHRDHODHL3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012175654-A1 TETRALINE SULFONAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS FACULTES UNIVERSITAIRES NOTRE-DAME DE LA PAIX (BE) 2012-12-27 WO disclosed
WO-2012175654-A1 TETRALINE SULFONAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS FACULTES UNIVERSITAIRES NOTRE-DAME DE LA PAIX (BE) 2012-12-27 WO disclosed